Table 2.
The ratio of combined GTT and HC compounds at growth inhibition of 50% (IC50) on glioma cancer 1321N1, SW1783, LN18 cells and combination index (CI) for each combination
Type of cell line | GTT:HC | IC50 a [μg/ml] | GTT b [μg/ml] | HC b [μg/ml] | Combination Index c (CI) |
---|---|---|---|---|---|
1321N1 |
10 : 3 |
12 |
100 |
75 |
0.55 ± 0.07 |
SW1783 |
20 : 1 |
2 |
79 |
95 |
0.54 ± 0.03 |
LN18 | 2 : 3 | 29 | 42 | 119 | 0.73 ± 0.03 |
aIC50 of combined compounds.
bIC50 of individual compound.
cCI < 1.0 indicates synergism; 0.9 < CI < 1.10, near additive; CI > 1.10 indicates antagonism.
The data are the average of three independent experiments.